alpha-Benzoyltriethylamine
Brand names,
alpha-Benzoyltriethylamine
Analogs
alpha-Benzoyltriethylamine
Brand Names Mixture
alpha-Benzoyltriethylamine
Chemical_Formula
C13H19NO
alpha-Benzoyltriethylamine
RX_link
http://www.rxlist.com/cgi/generic3/diethprop.htm
alpha-Benzoyltriethylamine
fda sheet
alpha-Benzoyltriethylamine
msds (material safety sheet)
alpha-Benzoyltriethylamine
Synthesis Reference
No information avaliable
alpha-Benzoyltriethylamine
Molecular Weight
205.296 g/mol
alpha-Benzoyltriethylamine
Melting Point
No information avaliable
alpha-Benzoyltriethylamine
H2O Solubility
No information avaliable
alpha-Benzoyltriethylamine
State
No information avaliable
alpha-Benzoyltriethylamine
LogP
2.951
alpha-Benzoyltriethylamine
Dosage Forms
25 mg tablets and 75 mg controlled-release tablets.
alpha-Benzoyltriethylamine
Indication
Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
alpha-Benzoyltriethylamine
Pharmacology
Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.
alpha-Benzoyltriethylamine
Absorption
Diethylpropion is rapidly absorbed from the GI tract after oral administration.
alpha-Benzoyltriethylamine
side effects and Toxicity
The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.
alpha-Benzoyltriethylamine
Patient Information
No information avaliable
alpha-Benzoyltriethylamine
Organisms Affected
Humans and other mammals